Information updates

CHOICE Allergen Immunotherapy study

CHOICE study coordinators are looking for clinicians to join them in an international multi-centre academic project, which looks at factors that drive the prescription of allergen immunotherapy in real-life clinical settings.

Study title: CHOICE = “Criteria Used by Health Professionals on the Selection of Allergen Immunotherapy in Real Clinical Practice: an international E-survey”.

National CHOICE study coordinators: Prof Connie Katelaris AM, Head of Immunology, Campbelltown Hospital, Dr Narinder Kaur, Clinical Immunologist and Allergist, Dr Margaret Li, Allergy and Immunology Fellow, SCHN.

To be a part of this project, clinicians are required to complete a quick 10-minute web-based survey about current practice when prescribing allergen immunotherapy and also a short questionnaire for each patient that you are prospectively planning to commence on allergen immunotherapy.

All data will be anonymous and stored securely. For further information, please see the PDF information sheet for clinicians  pdfClinician Information Sheet672.98 KB

If you are interested, please email This email address is being protected from spambots. You need JavaScript enabled to view it. with your contact details, as well as your current practice setting. If you are working in a public hospital, please include your head of department in the email. We will be in touch with the next steps.

This news item was issued on 17 January 2023 by Jill Smith, CEO of the Australasian Society of Clinical Immunology and Allergy (ASCIA). ASCIA is the peak professional body for clinical immunology and allergy in Australia and New Zealand. 

Mod ASCIA Member
Donate to AIFA
go to NAC website

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links


ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Information Partner

Official Information Partner of Healthdirect Australia